A clinical trial to evaluate the effect of green tea in comparison with placebo on treatment of uncomplicated urinary tract infection in women by using urine culture and symptoms of disease

INTERVENTION: In control group one capsule of starch is given daily for three days. They receive co‐trimaxazole 480 mg twice daily for 3 days concurrently. In intervention group, participants receive green tea as one capsule daily for three days. They receive co‐trimaxazole 480 mg twice daily for 3 days concurrently. Each capsule contains the freeze dried extract of iranian green tea. That equates to approximately 150 mg of EGC per capsule. HPLC is used to determine the amount of EGC per gram of green tea. Intervention 1: In intervention group, participants receive green tea as one capsule daily for three days. They receive co‐trimaxazole 480 mg twice daily for 3 days concurrently. Each capsule contains the freeze dried extract of iranian green tea. That equates to approximately 150 mg of EGC per capsule. HPLC is used to determine the amount of EGC per gram of green tea. Intervention 2: In control group one capsule of starch is given daily for three days. They receive co‐trimaxazole 480 mg twice daily for 3 days concurrently. Treatment ‐ Drugs CONDITION: Acute cystitis Acute cystitis. ; Acute cystitis PRIMARY OUTCOME: Urinary tract infection symtoms such as dysuria, frequent urination, suprapubic pain, and hematuria. Timepoint: Daily for three days. Method of measurement: Questionnaire. SECONDARY OUTCOME: Urine culture. Timepoint: Day 0 and 4. Method of measurement: Cultured pathogen. INCLUSION CRITERIA: Iclusion criteria: age 18‐ 55 years old; women with uncomplicated urinary tract infection that recieve cotrimaxazole concurrently Exclusion Criteria: Pregnancy; HIV positive; Diabetes; Other infections